Analysis of the key implementation points for changes in safety information of marketed drugs in China

doi:10.3969/j.issn.1672-3384.2024.04.014

PDF(430 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (4) : 73-77. DOI: 10.3969/j.issn.1672-3384.2024.04.014

Pharmacy Adminstration

Analysis of the key implementation points for changes in safety information of marketed drugs in China

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(4): 73-77 https://doi.org/10.3969/j.issn.1672-3384.2024.04.014

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(430 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-09-12	2024-04-24
Issue Date
2024-04-24

Please choose a citation manager

Content to export